Publications

2017

Durand M, Jain M, Robinson B, Aronowitz E, Douahy YE, Leung R, et al. Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland. BJU Int. 2017;119(3):414-423.
Gullett JC, Westblade LF, Green DA, Whittier S, Burd EM. The Brief Case: Too Beta To Be a "B". J Clin Microbiol. 2017;55(6):1604-1607.
Nguyen DP, O'Malley P, Awamlh BA, Furrer M-, Mongan NP, Robinson BD, et al. Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer. Clin Genitourin Cancer. 2017;15(2):256-262.e1.
McHugh D, Caduff N, Barros MH, Rämer PC, Raykova A, Murer A, et al. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell Host Microbe. 2017;22(1):61-73.e7.
Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, et al. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol. 2017;35(12):673.e9-673.e14.
Jia L, Yan F, Cao W, Chen Z, Zheng H, Li H, et al. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. J Biol Chem. 2017;292(7):2966-2978.
Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, et al. Personalized and Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462-477.
Alter RA, White TG, Fanous AA, Chakraborty S, Filippi CG, Pisapia DJ, et al. Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma. J Exp Ther Oncol. 2017;12(1):67-71.
Prandi D, Baca SC, Romanel A, Barbieri CE, Mosquera J-, Fontugne J, et al. Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol. 2017;18(1):80.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700